en · de · es · fr · pt
selank-notes.peptides5388.com › Info › Peptide Identity And Structure — Background and Details

Peptide Identity And Structure — Background and Details

By Editorial Desk · published 2026-06-19 · last reviewed 2026-08-01 · Info

mass spectrometry comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.

Updated 2026-08-01. Numbers and descriptions here follow the published literature rather than marketing material.

Peptide Identity and Structure

Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro, written TKPRPGP in one-letter notation. Its structure consists of the immunomodulatory tetrapeptide tuftsin, Thr-Lys-Pro-Arg, extended at the carboxyl terminus by a Pro-Gly-Pro segment. The molecular formula is commonly given as C33H57N11O9, corresponding to a monoisotopic mass near 751.4 Da and an average molecular mass near 751.9 Da. All seven residues are proteinogenic amino acids, and the molecule carries no modified side chains or non-natural linkages.

The compound was designed at the Institute of Molecular Genetics of the Russian Academy of Sciences during the 1980s and 1990s. The stated design goal was to retain the immunomodulatory and central nervous system activity attributed to tuftsin while improving resistance to enzymatic breakdown. Adding a proline-rich tail to the short parent peptide was a deliberate strategy, because proline residues restrict the conformations available to many peptidases. The same laboratory produced Semax, an ACTH fragment analog, and both compounds were developed in parallel as short, enzymatically stabilized peptides intended for intranasal use.

Selank is not a naturally occurring peptide and has no known endogenous counterpart in human physiology. Russian-language sources frequently call it TP-7, while English-language sources use the name Selank almost exclusively. Database indexing is uneven, partly because early reports appeared in regional journals that are not widely cataloged. Some summaries describe the material as a tuftsin analog and others as a synthetic heptapeptide; the labels overlap rather than conflict. Citing the primary sequence resolves ambiguity more reliably than the research or trade name alone.

Selank Handling, Stability, and Analysis

Lyophilized selank is normally supplied as a dry powder and is considered stable for extended periods when kept cold and dry. Moisture uptake is the main practical threat, because absorbed water promotes both hydrolysis and aggregation in the solid state. Vials are usually warmed to room temperature before opening so that condensation does not form on the powder. Supplier documentation commonly specifies -20 °C for routine storage, with -80 °C used for material intended to be archived for years.

Once dissolved, the peptide is markedly less stable than the dry powder. Aqueous solutions are subject to backbone hydrolysis and to microbial growth when they are handled without sterile technique. Buffered solutions near neutral pH are common for short-term laboratory work, while acidic conditions are sometimes used to improve solubility. Analytical laboratories generally prepare working solutions fresh rather than storing them, and a residual water film left in a reopened vial can seed degradation even when the container appears dry.

Selank at a glance

PropertyValueNotes
Peptide sequenceThr-Lys-Pro-Arg-Pro-Gly-ProSeven residues; tuftsin plus a Pro-Gly-Pro tail
Molecular formulaC33H57N11O9Commonly reported value for the free peptide
Monoisotopic massRoughly 751.4 DaAverage molecular mass near 751.9 Da
AppearanceWhite to off-white powderTypically supplied as a lyophilized solid
Solubility classFreely soluble in waterAlso dissolves in saline and other polar solvents

Stability, Handling, and Analytical Control

Peptide bonds are vulnerable to protease attack, and Selank is no exception. Measured half-life in serum is short, on the order of minutes in several reports, which explains why intranasal administration is the common route described in the literature. Absorption across the nasal mucosa partially bypasses first-pass hepatic metabolism. Quantitative data on human bioavailability remain limited and are difficult to compare across studies.

Lyophilised material kept dry at minus 20 degrees Celsius or colder is the most stable form, and suppliers commonly state a shelf life of two years or more under those conditions. Once dissolved, degradation accelerates through hydrolysis and deamidation, particularly at alkaline pH or elevated temperature. Working solutions are usually divided into single-use aliquots to avoid repeated freeze-thaw cycles. The choice of reconstitution solvent affects both stability and the ionic strength of the final preparation.

Related pages on this site

Mechanism and Evidence Base

Clinical evidence comes mainly from small studies conducted in Russia, several of which were open-label or lacked robust blinding. Reported outcomes include lower anxiety scores, changes in attention measures, and effects on asthenic states following illness. Sample sizes are typically in the tens of participants, and independent replication outside the region is scarce. Reviews published in English generally note the limited methodological quality of the underlying trials. Whether the compound produces clinically meaningful effects under rigorous conditions remains unresolved.

Proposed mechanisms center on modulation of the GABA system, but no single molecular target has been confirmed. Rodent studies report changes in GABA-A receptor expression and in the turnover of serotonin, dopamine, and norepinephrine in several brain regions. Increases in brain-derived neurotrophic factor and its receptor have also been described after repeated administration. These findings come largely from animal models, and the degree to which they describe human neurochemistry remains an open question. The mechanism is best characterized as multi-system and not fully resolved.

Pharmacokinetic data are limited. Like most short peptides, Selank is vulnerable to plasma and tissue peptidases, and its measured half-life in circulation is short, on a minutes scale. The Pro-Gly-Pro tail slows this degradation but does not eliminate it. Intranasal administration is the route described in most reports, with absorption through the nasal mucosa and a hypothesized path into the central nervous system that avoids the blood-brain barrier. Direct measurements of human brain exposure are unavailable, so distribution claims rest on inference from animal work.

Selank Background And Chemical Identity

The primary structure of Selank is Thr-Lys-Pro-Arg-Pro-Gly-Pro, corresponding to the molecular formula C33H57N11O9 and a monoisotopic mass of roughly 751.9 daltons. The N-terminal threonine and the arginine residue in the fourth position are shared with tuftsin, which carries the sequence Thr-Lys-Pro-Arg. The three additional residues at the C-terminus, Pro-Gly-Pro, extend the chain and are associated with greater resistance to enzymatic degradation. This extension also separates Selank from the shorter parent peptide.

Naming conventions place Selank in the same research family as Semax, another Russian-developed peptide investigated for cognitive effects. The two compounds share a lineage but differ in sequence and in the biological systems proposed as their targets. Semax descends from ACTH fragments, whereas Selank descends from tuftsin. Publications sometimes identify Selank by its full peptide sequence or by laboratory codes rather than one uniform trade name. Because replication outside Russia is limited, reports on its properties are best read alongside the study design and the purity of the material tested.

Further detail

On March 10, 2014, the first Dunkin' Donuts/Baskin-Robbins combination store in Southern California opened in Ramona. This is Dunkin' Donuts' third California shop to open, following shops in Barstow and on Camp Pendleton. Since March 2014, Dunkin' Donuts has opened several additional locations throughout California, including the Los Angeles area. Dunkin' Donuts shops opened in the San Francisco Bay Area in Walnut Creek, Half Moon Bay, and American Canyon in 2016, as well as South San Francisco and Fremont, in 2017.

During the 1990s, people in the West were also interested in the radioactive hazards of nuclear facilities, decommissioned nuclear submarines, and the processing of nuclear waste or spent nuclear fuel. It was also known in the early 1990s that the USSR had transported radioactive material to the Barents Sea and Kara Sea, which was later confirmed by the Russian parliament. The crash of the K-141 Kursk submarine in 2000 in the west further raised concerns. In the past, there were accidents involving submarines K-19, K-8, a K-129, K-27, K-219 and K-278 Komsomolets.

Other scarab beetles, for example, Coprophanaeus ensifer, build their burrows near carcasses for easier transportation of carrion pieces to offspring. Beetles that feed on human remains are important in forensic science. Terrestrial beetles such as checkered beetles and dermestid beetles colonize bodies in a predictable sequence and have well-characterized life cycles, so they can sometimes be used to estimate time of death. Aquatic beetles are less useful for estimating time of death but can cause physical damage to submerged bodies that must be distinguished from inflicted injuries when determining cause of death. For example, the facultatively necrophagous diving beetle Meridiorhantus validus creates postmortem channels and chambers in human bodies that must be differentiated from antemortem piercing injuries.

Sources: en.wikipedia.org

Supporting material

=== EC 2.7.4: Phosphotransferases with a phosphate group as acceptor === EC 2.7.4.1: ATP-polyphosphate phosphotransferase EC 2.7.4.2: phosphomevalonate kinase EC 2.7.4.3: adenylate kinase EC 2.7.4.4: nucleoside-phosphate kinase EC 2.7.4.5: deleted, now included with EC 2.7.4.14 cytidylate kinase EC 2.7.4.6: nucleoside-diphosphate kinase EC 2.7.4.7: phosphomethylpyrimidine kinase EC 2.7.4.8: guanylate kinase EC 2.7.4.9: dTMP kinase EC 2.7.4.10: nucleoside-triphosphate—adenylate kinase EC 2.7.4.11: (deoxy)adenylate kinase EC 2.7.4.12: T2-induced deoxynucleotide kinase EC 2.7.4.13: (deoxy)nucleoside-phosphate kinase EC 2.7.4.14: cytidylate kinase EC 2.7.4.15: thiamine-diphosphate kinase EC 2.7.4.16: thiamine-phosphate kinase EC 2.7.4.17: 3-phosphoglyceroyl-phosphate—polyphosphate phosphotransferase EC 2.7.4.18: farnesyl-diphosphate kinase EC 2.7.4.19: 5-methyldeoxycytidine-5′-phosphate kinase EC 2.7.4.20: dolichyl-diphosphate—polyphosphate phosphotransferase EC 2.7.4.21: inositol-hexakisphosphate kinase EC 2.7.4.22: UMP kinase EC 2.7.4.23: ribose 1,5-bisphosphate phosphokinase EC 2.7.4.24: diphosphoinositol-pentakisphosphate kinase EC 2.7.4.25: (d)CMP kinase EC 2.7.4.26: isopentenyl phosphate kinase EC 2.7.4.27: [pyruvate, phosphate dikinase]-phosphate phosphotransferase EC 2.7.4.28: [pyruvate, water dikinase]-phosphate phosphotransferase EC 2.7.4.29: Kdo2-lipid A phosphotransferase EC 2.7.4.30: Now EC 2.7.8.43, lipid A phosphoethanolamine transferase EC 2.7.4.31: [5-(aminomethyl)furan-3-yl]methyl phosphate kinase EC 2.7.4.32: farnesyl phosphate kinase EC 2.7.4.33: AMP-polyphosphate phosphotransferase EC 2.7.4.34: GDP-polyphosphate phosphotransferase

Protein nuclear magnetic resonance is performed on aqueous samples of highly purified protein. Usually, the sample consists of between 300 and 600 microlitres with a protein concentration in the range 0.1 – 3 millimolar. The source of the protein can be either natural or produced in a production system using recombinant DNA techniques through genetic engineering. Recombinantly expressed proteins are usually easier to produce in sufficient quantity, and this method makes isotopic labeling possible. The purified protein is usually dissolved in a buffer solution and adjusted to the desired solvent conditions. The NMR sample is prepared in a thin-walled glass tube.

This could be used, for example, in a touchscreen that registers reflected light from a finger or stylus. Many materials and biological systems are sensitive to, or dependent on, light. Grow lights use LEDs to increase photosynthesis in plants, and bacteria and viruses can be removed from water and other substances using UV LEDs for sterilization. LEDs of certain wavelengths have also been used for light therapy treatment of neonatal jaundice and acne. UV LEDs, with spectra range of 220 nm to 395 nm, have other applications, such as water/air purification, surface disinfection, glue curing, free-space non-line-of-sight communication, high performance liquid chromatography, UV curing dye printing, phototherapy (295 nm Vitamin D, 308 nm Excimer lamp or laser replacement), medical/ analytical instrumentation, and DNA absorption. LEDs have also been used as a medium-quality voltage reference in electronic circuits. The forward voltage drop (about 1.7 V for a red LED or 1.2V for an infrared) can be used instead of a Zener diode in low-voltage regulators. Red LEDs have the flattest I/V curve above the knee. Nitride-based LEDs have a fairly steep I/V curve and are useless for this purpose. Although LED forward voltage is far more current-dependent than a Zener diode, Zener diodes with breakdown voltages below 3 V are not widely available.

David Nuttall. Deputy Director, Neurodiversity, Disability and Learning Disability, Department of Health and Social Care. For services to People with Down Syndrome. Hannah Louise O'Callaghan. Co-Founder, Love Grace. For services to Charitable Fundraising and Tackling Violence Against Women. Kathleen Margaret O'Hare. Board Member, Belfast Metropolitan College and Member, Northern Ireland Council for the Curriculum. For services to Education in Northern Ireland. Dr. Tunde Okewale, MBE. Barrister. For services to Criminal Justice and Social Mobility. Dr. Sandra Ngozi Okoro. Lately Senior Vice President and General Counsel, World Bank. For services to Diversity in International Finance. Dr. Robert Leslie Orford. Chief Scientific Advisor for Health, Welsh Government. For services to Health Sciences and Evidence in Health Policy. David John O'Sullivan. Chief Optometric Advisor, Welsh Government. For services to Eye Care in Wales. Professor Nicholas Ossei-Gerning. Course Co-Director, Africa PCR Conference. For services to the Field of Interventional Cardiology. Mildred Baer Palley. Philanthropist. For services to the Arts and to Education. Brian Andrew Palmer. Founder and Chief Executive, Tharsus Group Ltd. For services to Manufacturing and Skills. Catherine Jane Parry. Lately Election Agent, Labour Party. For Political and Public Service. Munir Patel. Chief Executive Officer, XRAIL Group. For services to Rail Exports. Sarah Pateman. Community Safety Manager, Stevenage Borough Council. For services to the Victims of Domestic Abuse in Hertfordshire. Dr. Graham Paterson.

Sources: en.wikipedia.org

Frequently asked questions

What is the primary sequence of Selank?

The sequence is Thr-Lys-Pro-Arg-Pro-Gly-Pro, written TKPRPGP in one-letter code. It combines the tetrapeptide tuftsin with a carboxyl-terminal Pro-Gly-Pro extension. This full sequence identifies the molecule more precisely than the research name.

Is Selank found naturally in the body?

No peptide with this exact sequence has been identified as an endogenous substance. It is a laboratory-designed analog of tuftsin, a naturally occurring immunomodulatory tetrapeptide. The Pro-Gly-Pro extension has no known natural source.

Why does the peptide contain three proline residues?

Proline introduces conformational constraints that make a peptide less accessible to common peptidases. This is a standard stabilization strategy in peptide design. The added residues also increase the distance between the active tuftsin portion and typical cleavage sites.

How should selank powder be stored?

Sealed, desiccated storage at -20 °C or colder is the standard recommendation for research-grade material. Vials should reach room temperature before they are opened, which limits condensation. Repeated temperature cycling is discouraged.

Network